LinkedIn Profile

Access Magnasense historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:magnasense 2606526 May 29th, 2019 12:00AM Magnasense Technologies 74 4.00 Open Biotechnology May 29th, 2019 04:08PM May 29th, 2019 04:08PM Magnasense Technologies Superior Point of Care assays utilising super-paramagnetic labelled antibodies - Magnetic Immuno Assay (MIA). Great assay performance coupled with low cost. Magnasense Technologies has developed a sensitive, precise, and elegant system for performing Point-of-Care (PoC) lateral flow immunoassays. Paramagnetic labelled antibodies enable enhanced sensitivity as the entire volume of the capture zone is quantified, unlike optical / fluorescent methods where only the surface is measured. Optics, light sources and colour reagents are unnecessary. The system extremely sensitive, while being robust, easy to use and inexpensive. Applications include human and veterinary healthcare, food purity and environmental testing and anywhere where a rapid, precise, quantitative result is required. Microwell assays and tests based on other lateral flow technologies can be readily transferred to the Magnasense Technologies Magnia® platform. A rapid, quantitative assay for C-Reactive Protein (Magnia® CRP) is available and tests for infectious diseases are under advanced development. Magnasense Technologies is actively looking for partners for the development and commercialisation of these and further assays. The Magnia® reader is sensitive, precise and with a very wide dynamic range enabling one to obtain full benefit from the quality of the reagents used. The Magnia® reader can be easily and inexpensively modified to accommodate most lateral flow cassettes making the transfer of existing products to the Magnia® platform simple, fast and low cost. The Magnia® reader is lightweight, robust and battery powered making it a very suitable for point of care and field testing. Contact Magnasense Technologies for further information. (info@magnasense.com). We look forward to hearing from you Open Magnetic immunoassay, Near Patient testing, Point of Care testing, Veterinary testing, Mycotoxin testing, Food adulteration, Environmental testing, Pathogen testing, Infectious diseases, Cardiac disease, Field Testing, Point of Need testing, Lateral flow testing, CRP Open Rajatorpantie 41 C Vantaa FI 01640 Magnasense Health Care Health Care Equipment & Services
private:magnasense 2606526 Mar 9th, 2018 12:00AM Magnasense Technologies 65 5.00 Open Biotechnology Mar 9th, 2018 03:27PM Mar 9th, 2018 03:27PM Open Magnasense Health Care Health Care Equipment & Services
private:magnasense 2606526 Feb 17th, 2018 12:00AM Magnasense Technologies 64 5.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Magnasense Technologies Superior Point of Care assays utilising super-paramagnetic labelled antibodies - Magnetic Immuno Assay (MIA). Great assay performance coupled with low cost. Magnasense Technologies has developed a sensitive, precise, and elegant system for performing Point-of-Care (PoC) lateral flow immunoassays. Paramagnetic labelled antibodies enable enhanced sensitivity as the entire volume of the capture zone is quantified, unlike optical / fluorescent methods where only the surface is measured. Optics, light sources and colour reagents are unnecessary. The system extremely sensitive, while being robust, easy to use and inexpensive. Applications include human and veterinary healthcare, food purity and environmental testing and anywhere where a rapid, precise, quantitative result is required. Microwell assays and tests based on other lateral flow technologies can be readily transferred to the Magnasense Technologies Magnia® platform. A rapid, quantitative assay for C-Reactive Protein (Magnia® CRP) is available and tests for infectious diseases are under advanced development. Magnasense Technologies is actively looking for partners for the development and commercialisation of these and further assays. The Magnia® reader is sensitive, precise and with a very wide dynamic range enabling one to obtain full benefit from the quality of the reagents used. The Magnia® reader can be easily and inexpensively modified to accommodate most lateral flow cassettes making the transfer of existing products to the Magnia® platform simple, fast and low cost. The Magnia® reader is lightweight, robust and battery powered making it a very suitable for point of care and field testing. Contact Magnasense Technologies for further information. (info@magnasense.com). We look forward to hearing from you Magnasense Health Care Health Care Equipment & Services
private:magnasense 2606526 Feb 16th, 2018 12:00AM Magnasense Technologies 64 5.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Magnasense Technologies Superior Point of Care assays utilising super-paramagnetic labelled antibodies - Magnetic Immuno Assay (MIA). Great assay performance coupled with low cost. Magnasense Technologies has developed a sensitive, precise, and elegant system for performing Point-of-Care (PoC) lateral flow immunoassays. Paramagnetic labelled antibodies enable enhanced sensitivity as the entire volume of the capture zone is quantified, unlike optical / fluorescent methods where only the surface is measured. Optics, light sources and colour reagents are unnecessary. The system extremely sensitive, while being robust, easy to use and inexpensive. Applications include human and veterinary healthcare, food purity and environmental testing and anywhere where a rapid, precise, quantitative result is required. Microwell assays and tests based on other lateral flow technologies can be readily transferred to the Magnasense Technologies Magnia® platform. A rapid, quantitative assay for C-Reactive Protein (Magnia® CRP) is available and tests for infectious diseases are under advanced development. Magnasense Technologies is actively looking for partners for the development and commercialisation of these and further assays. The Magnia® reader is sensitive, precise and with a very wide dynamic range enabling one to obtain full benefit from the quality of the reagents used. The Magnia® reader can be easily and inexpensively modified to accommodate most lateral flow cassettes making the transfer of existing products to the Magnia® platform simple, fast and low cost. The Magnia® reader is lightweight, robust and battery powered making it a very suitable for point of care and field testing. Contact Magnasense Technologies for further information. (info@magnasense.com). We look forward to hearing from you Magnasense Health Care Health Care Equipment & Services
private:magnasense 2606526 Feb 15th, 2018 12:00AM Magnasense Technologies 64 5.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Magnasense Technologies Superior Point of Care assays utilising super-paramagnetic labelled antibodies - Magnetic Immuno Assay (MIA). Great assay performance coupled with low cost. Magnasense Technologies has developed a sensitive, precise, and elegant system for performing Point-of-Care (PoC) lateral flow immunoassays. Paramagnetic labelled antibodies enable enhanced sensitivity as the entire volume of the capture zone is quantified, unlike optical / fluorescent methods where only the surface is measured. Optics, light sources and colour reagents are unnecessary. The system extremely sensitive, while being robust, easy to use and inexpensive. Applications include human and veterinary healthcare, food purity and environmental testing and anywhere where a rapid, precise, quantitative result is required. Microwell assays and tests based on other lateral flow technologies can be readily transferred to the Magnasense Technologies Magnia® platform. A rapid, quantitative assay for C-Reactive Protein (Magnia® CRP) is available and tests for infectious diseases are under advanced development. Magnasense Technologies is actively looking for partners for the development and commercialisation of these and further assays. The Magnia® reader is sensitive, precise and with a very wide dynamic range enabling one to obtain full benefit from the quality of the reagents used. The Magnia® reader can be easily and inexpensively modified to accommodate most lateral flow cassettes making the transfer of existing products to the Magnia® platform simple, fast and low cost. The Magnia® reader is lightweight, robust and battery powered making it a very suitable for point of care and field testing. Contact Magnasense Technologies for further information. (info@magnasense.com). We look forward to hearing from you Magnasense Health Care Health Care Equipment & Services
private:magnasense 2606526 Feb 14th, 2018 12:00AM Magnasense Technologies 64 5.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Magnasense Technologies Superior Point of Care assays utilising super-paramagnetic labelled antibodies - Magnetic Immuno Assay (MIA). Great assay performance coupled with low cost. Magnasense Technologies has developed a sensitive, precise, and elegant system for performing Point-of-Care (PoC) lateral flow immunoassays. Paramagnetic labelled antibodies enable enhanced sensitivity as the entire volume of the capture zone is quantified, unlike optical / fluorescent methods where only the surface is measured. Optics, light sources and colour reagents are unnecessary. The system extremely sensitive, while being robust, easy to use and inexpensive. Applications include human and veterinary healthcare, food purity and environmental testing and anywhere where a rapid, precise, quantitative result is required. Microwell assays and tests based on other lateral flow technologies can be readily transferred to the Magnasense Technologies Magnia® platform. A rapid, quantitative assay for C-Reactive Protein (Magnia® CRP) is available and tests for infectious diseases are under advanced development. Magnasense Technologies is actively looking for partners for the development and commercialisation of these and further assays. The Magnia® reader is sensitive, precise and with a very wide dynamic range enabling one to obtain full benefit from the quality of the reagents used. The Magnia® reader can be easily and inexpensively modified to accommodate most lateral flow cassettes making the transfer of existing products to the Magnia® platform simple, fast and low cost. The Magnia® reader is lightweight, robust and battery powered making it a very suitable for point of care and field testing. Contact Magnasense Technologies for further information. (info@magnasense.com). We look forward to hearing from you Magnasense Health Care Health Care Equipment & Services
private:magnasense 2606526 Feb 13th, 2018 12:00AM Magnasense Technologies 64 5.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Magnasense Technologies Superior Point of Care assays utilising super-paramagnetic labelled antibodies - Magnetic Immuno Assay (MIA). Great assay performance coupled with low cost. Magnasense Technologies has developed a sensitive, precise, and elegant system for performing Point-of-Care (PoC) lateral flow immunoassays. Paramagnetic labelled antibodies enable enhanced sensitivity as the entire volume of the capture zone is quantified, unlike optical / fluorescent methods where only the surface is measured. Optics, light sources and colour reagents are unnecessary. The system extremely sensitive, while being robust, easy to use and inexpensive. Applications include human and veterinary healthcare, food purity and environmental testing and anywhere where a rapid, precise, quantitative result is required. Microwell assays and tests based on other lateral flow technologies can be readily transferred to the Magnasense Technologies Magnia® platform. A rapid, quantitative assay for C-Reactive Protein (Magnia® CRP) is available and tests for infectious diseases are under advanced development. Magnasense Technologies is actively looking for partners for the development and commercialisation of these and further assays. The Magnia® reader is sensitive, precise and with a very wide dynamic range enabling one to obtain full benefit from the quality of the reagents used. The Magnia® reader can be easily and inexpensively modified to accommodate most lateral flow cassettes making the transfer of existing products to the Magnia® platform simple, fast and low cost. The Magnia® reader is lightweight, robust and battery powered making it a very suitable for point of care and field testing. Contact Magnasense Technologies for further information. (info@magnasense.com). We look forward to hearing from you Magnasense Health Care Health Care Equipment & Services
private:magnasense 2606526 Feb 12th, 2018 12:00AM Magnasense Technologies 64 5.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Magnasense Technologies Superior Point of Care assays utilising super-paramagnetic labelled antibodies - Magnetic Immuno Assay (MIA). Great assay performance coupled with low cost. Magnasense Technologies has developed a sensitive, precise, and elegant system for performing Point-of-Care (PoC) lateral flow immunoassays. Paramagnetic labelled antibodies enable enhanced sensitivity as the entire volume of the capture zone is quantified, unlike optical / fluorescent methods where only the surface is measured. Optics, light sources and colour reagents are unnecessary. The system extremely sensitive, while being robust, easy to use and inexpensive. Applications include human and veterinary healthcare, food purity and environmental testing and anywhere where a rapid, precise, quantitative result is required. Microwell assays and tests based on other lateral flow technologies can be readily transferred to the Magnasense Technologies Magnia® platform. A rapid, quantitative assay for C-Reactive Protein (Magnia® CRP) is available and tests for infectious diseases are under advanced development. Magnasense Technologies is actively looking for partners for the development and commercialisation of these and further assays. The Magnia® reader is sensitive, precise and with a very wide dynamic range enabling one to obtain full benefit from the quality of the reagents used. The Magnia® reader can be easily and inexpensively modified to accommodate most lateral flow cassettes making the transfer of existing products to the Magnia® platform simple, fast and low cost. The Magnia® reader is lightweight, robust and battery powered making it a very suitable for point of care and field testing. Contact Magnasense Technologies for further information. (info@magnasense.com). We look forward to hearing from you Magnasense Health Care Health Care Equipment & Services
private:magnasense 2606526 Feb 11th, 2018 12:00AM Magnasense Technologies 64 5.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Magnasense Technologies Superior Point of Care assays utilising super-paramagnetic labelled antibodies - Magnetic Immuno Assay (MIA). Great assay performance coupled with low cost. Magnasense Technologies has developed a sensitive, precise, and elegant system for performing Point-of-Care (PoC) lateral flow immunoassays. Paramagnetic labelled antibodies enable enhanced sensitivity as the entire volume of the capture zone is quantified, unlike optical / fluorescent methods where only the surface is measured. Optics, light sources and colour reagents are unnecessary. The system extremely sensitive, while being robust, easy to use and inexpensive. Applications include human and veterinary healthcare, food purity and environmental testing and anywhere where a rapid, precise, quantitative result is required. Microwell assays and tests based on other lateral flow technologies can be readily transferred to the Magnasense Technologies Magnia® platform. A rapid, quantitative assay for C-Reactive Protein (Magnia® CRP) is available and tests for infectious diseases are under advanced development. Magnasense Technologies is actively looking for partners for the development and commercialisation of these and further assays. The Magnia® reader is sensitive, precise and with a very wide dynamic range enabling one to obtain full benefit from the quality of the reagents used. The Magnia® reader can be easily and inexpensively modified to accommodate most lateral flow cassettes making the transfer of existing products to the Magnia® platform simple, fast and low cost. The Magnia® reader is lightweight, robust and battery powered making it a very suitable for point of care and field testing. Contact Magnasense Technologies for further information. (info@magnasense.com). We look forward to hearing from you Magnasense Health Care Health Care Equipment & Services
private:magnasense 2606526 Feb 10th, 2018 12:00AM Magnasense Technologies 64 5.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Magnasense Technologies Superior Point of Care assays utilising super-paramagnetic labelled antibodies - Magnetic Immuno Assay (MIA). Great assay performance coupled with low cost. Magnasense Technologies has developed a sensitive, precise, and elegant system for performing Point-of-Care (PoC) lateral flow immunoassays. Paramagnetic labelled antibodies enable enhanced sensitivity as the entire volume of the capture zone is quantified, unlike optical / fluorescent methods where only the surface is measured. Optics, light sources and colour reagents are unnecessary. The system extremely sensitive, while being robust, easy to use and inexpensive. Applications include human and veterinary healthcare, food purity and environmental testing and anywhere where a rapid, precise, quantitative result is required. Microwell assays and tests based on other lateral flow technologies can be readily transferred to the Magnasense Technologies Magnia® platform. A rapid, quantitative assay for C-Reactive Protein (Magnia® CRP) is available and tests for infectious diseases are under advanced development. Magnasense Technologies is actively looking for partners for the development and commercialisation of these and further assays. The Magnia® reader is sensitive, precise and with a very wide dynamic range enabling one to obtain full benefit from the quality of the reagents used. The Magnia® reader can be easily and inexpensively modified to accommodate most lateral flow cassettes making the transfer of existing products to the Magnia® platform simple, fast and low cost. The Magnia® reader is lightweight, robust and battery powered making it a very suitable for point of care and field testing. Contact Magnasense Technologies for further information. (info@magnasense.com). We look forward to hearing from you Magnasense Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.